• Home
  • About
  • Science & Pipeline
  • Patients
  • Leadership
  • Investors & Media
  • Careers
  • Contact Us
  • LinkedIn
  • Privacy
  • Terms of Use

Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board

by Kinnate | Sep 9, 2020 | News

Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board Laurie Smaldone Alsup, M.D. also joins as a board member SAN DIEGO, Calif.— September 9, 2020 — Kinnate Biopharma Inc., a biopharmaceutical company focused on the discovery and development of small...

Recent Posts

  • Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board
  • Kinnate Biopharma Closes $98 Million Series C Financing
  • Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer
  • Precision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year
  • Kinnate Biopharma Appoints Nima Farzan as Chief Executive Officer

Recent Comments

    Archives

    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • December 2019
    • April 2018

    Categories

    • Article
    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    LinkedIn
    Contact
    Privacy
    Terms of Use

    Kinnate Biopharma Inc., 3611 Valley Centre Drive, Suite 175, San Diego, CA 92130.

    © 2021 Kinnate Biopharma.

    Site by GOODLAB